Brokerages Set The Ensign Group, Inc. (NASDAQ:ENSG) Price Target at $204.60

Shares of The Ensign Group, Inc. (NASDAQ:ENSG) have earned a consensus rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $204.60.

ENSG has been the subject of several research analyst reports. UBS Group set a $230.00 target price on shares of The Ensign Group and gave the stock a “buy” rating in a research report on Friday, February 6th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Weiss Ratings reissued a “buy (b)” rating on shares of The Ensign Group in a report on Thursday, January 22nd. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Finally, Zacks Research raised The Ensign Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 26th.

The Ensign Group Stock Up 1.2%

ENSG stock opened at $202.43 on Thursday. The Ensign Group has a twelve month low of $118.73 and a twelve month high of $218.00. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $11.72 billion, a P/E ratio of 34.66, a PEG ratio of 1.96 and a beta of 0.83. The firm has a 50 day simple moving average of $197.57 and a 200-day simple moving average of $184.43.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.07. The Ensign Group had a net margin of 6.80% and a return on equity of 16.76%. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. During the same period in the prior year, the company posted $1.49 earnings per share. The firm’s quarterly revenue was up 20.2% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. On average, equities research analysts predict that The Ensign Group will post 5.59 earnings per share for the current fiscal year.

The Ensign Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend is Tuesday, March 31st. The Ensign Group’s dividend payout ratio is currently 4.45%.

Insider Activity

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of the stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $171.54, for a total transaction of $120,078.00. Following the sale, the director directly owned 23,552 shares of the company’s stock, valued at approximately $4,040,110.08. This represents a 2.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John O. Agwunobi sold 246 shares of the firm’s stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $179.82, for a total transaction of $44,235.72. Following the completion of the transaction, the director owned 9,233 shares in the company, valued at approximately $1,660,278.06. The trade was a 2.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 17,073 shares of company stock valued at $3,333,390 over the last three months. 3.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after acquiring an additional 14,590 shares during the period. Geneos Wealth Management Inc. raised its position in shares of The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after purchasing an additional 230 shares during the period. SBI Securities Co. Ltd. raised its position in shares of The Ensign Group by 872.4% during the 2nd quarter. SBI Securities Co. Ltd. now owns 282 shares of the company’s stock worth $44,000 after purchasing an additional 253 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of The Ensign Group by 3.6% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,268 shares of the company’s stock worth $504,000 after purchasing an additional 113 shares during the last quarter. Finally, Police & Firemen s Retirement System of New Jersey lifted its holdings in shares of The Ensign Group by 5.9% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 12,732 shares of the company’s stock worth $1,964,000 after purchasing an additional 710 shares during the last quarter. 96.12% of the stock is owned by institutional investors and hedge funds.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.